Cellular mechanisms of resistance to chronic oxidative stress

Free Radical Biology and Medicine

Volumn 24, Issue 9, 1998, Pages 1375-1389

  Sagara, Yutaka ^a   Dargusch, Richard ^a   Chambers, David ^a   Davis, John ^a   Schubert, David ^a   Maher, Pamela ^b  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Free radical; Glutamate toxicity; Glutathione metabolism; Oxidative stress; Reactive oxygen species

Indexed keywords

FREE RADICAL; GLUTATHIONE PEROXIDASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGING; ALZHEIMER DISEASE; ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; BCL-2-ASSOCIATED X PROTEIN; BIOLOGICAL TRANSPORT; CATALASE; CELL LINE; CELL SURVIVAL; CYSTATHIONINE; CYSTINE; DRUG RESISTANCE; GLUTAMATE-CYSTEINE LIGASE; GLUTAMIC ACID; GLUTATHIONE; HEAT-SHOCK PROTEINS; HOMOCYSTEINE; MICE; NEOPLASM PROTEINS; OXIDATIVE STRESS; OXIDOREDUCTASES; OXIDOREDUCTASES ACTING ON CH-CH GROUP DONORS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TIME FACTORS; UP-REGULATION;

ANIMALIA;

EID: 0031866530     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(97)00457-7     Document Type: Article

References (117)

1. Halliwell B. Oxidants and human disease Some new concepts . FASEB J. 1:1987;358-364.
2. Ames B. N., Shigenaga M. K., Hagen T. M. Oxidants, antioxidants, and the degenerative diseases of aging. Proc. Natl. Acad. Sci. USA. 90:1993;7915-7922.
3. Halliwell B., Gutteridge J. M. C. Free radicals in biology and medicine. 1993;Clarendon, Oxford, UK.
4. Keaney J. F. Jr, Vita J. A. Atherosclerosis, oxidative stress, and antioxidant protection in endothelium-derived relaxing factor action. Prog. Cardiovascular Dis. 38:1995;129-154.
5. Adelman R., Saul R. L., Ames B. N. Oxidative damage to DNA Relation to species metabolic rate and life span . Proc. Natl. Acad. Sci. USA. 85:1988;2706-2710.
6. Muehlmatter D., Larsson R., Cerutti P. Active oxygen induced strand breakage and poly ADP-ribosylation in promotable and nonpromotable JB6 mouse epidermal cells. Carcinogenesis. 9:1988;239-247.
7. Coyle J. T., Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science. 262:1993;689-695.
8. Riederer P., Sofic E., Rausch W. D., Schmidt B., Reynolds G. P., Jellinger K., Youdim M. B. H. Transition metals, ferritin, glutathione and ascorbic acid in Parkinsonian brains. J. Neurochem. 52:1989;515-520.
9. Bergeron C. Oxidative stress Its role in the pathogenesis of amyotrophic lateral sclerosis . J. Neurol. Sci. 129:1995;S81-S84.
10. Williams L. R. Oxidative stress, age-related neuro-degeneration, and the potential for neurotrophic treatment. Cerebro. Brain Metab. Rev. 7:1995;55-73.
11. Benzi G., Moretti A. Are reactive oxygen species involved in Alzheimer's disease? Neurobiol. Aging. 16:1995;661-674.
12. Beal M. F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:1995;357-366.
13. Jenner P. Oxidative stress as a cause of Parkinson's disease. Acta Neurol. Scand. 136:(Suppl.):1991;6-15.
14. Gerlach M., Ben-Shachar D., Riederer P., Youdim M. B. H. Altered brain metabolism of iron as a cause of neurodegenerative diseases? J. Neurochem. 63:1994;793-807.
15. Hall E. D., Braughler J. M. Central nervous system trauma and stroke. II. physiological and pharmacological evidence for involvement of oxygen radicals and lipid peroxidation. Free Radic. Biol. Med. 6:1989;303-313.
16. Meister A. Glutathione metabolism. Meth. Enzymol. 251:1995;3-7.
17. Meister A. Glutathione deficiency produced by inhibition of its synthesis, and its reversal applications in research and therapy . Pharmacol. Ther. 51:1991;155-194.
18. Bast A., Haenen G. R. Regulation of lipid peroxidation by glutathione and lipoic acid involvement of liver microsomal vitamin E free radical reductase . Adv. Exp. Med. Biol. 264:1990;111-116.
19. Fahey R. C., Sundquist A. R. Evolution of glutathione metabolism. Adv. Enzymol. 64:1991;1-53.
20. Mårtensson J., Jain A., Frayer W., Meister A. Glutathione metabolism in the lung inhibition of its synthesis leads to lamellar body and mitochondrial defects . Proc. Natl. Acad. Sci. USA. 86:1989;5296-5300.
21. Bannai S., Ishii T. Transport of cystine and cysteine and cell growth in cultured human diploid fibroblasts effect of glutamate and homocysteate . J. Cell. Physiol. 112:1982;265-272.
22. Christensen H. N. Role of amino acid transport and countertransport in nutrition and metabolism. Physiol. Rev. 70:1990;43-77.
23. Makowske M., Christensen H. N. Contrasts in transport systems for anionic amino acids in hepatocytes and a hepatoma cell line HTC. J. Biol. Chem. 257:1982;5663-5670.
24. Bannai S. Transport of cystine and cysteine in mammalian cells. Biochim. Biophys. Acta. 779:1984;289-306.
25. Murphy T. H., Miyamoto M., Sastre A., Schnaar R. L., Coyle J. T. Glutamate toxicity in a neuronal cell line involves inhibition of cystine transport leading to oxidative stress. Neuron. 2:1989;1547-1558.
26. Cho Y., Bannai S. Uptake of glutamate and cystine in C6 glioma cells and in cultured astrocytes. J. Neurochem. 55:1990;2091-2097.
27. Murphy T. H., Schnaar R. L., Coyle J. T. Immature cortical neurons are uniquely sensitive to glutamate toxicity by inhibition of cystine uptake. FASEB J. 4:1990;1624-1633.
28. Sagara J., Miura K., Bannai S. Cystine uptake and glutathione level in fetal brain cells in primary culture and in suspension. J. Neurochem. 61:1993;1667-1671.
29. Oka A., Belliveau M. J., Rosenberg P. A., Volpe J. J. Vulnerability of oligodendroglia to glutamate pharmacology, mechanisms, and prevention . J. Neurosci. 13:1993;1441-1453.
30. Davis J. B., Maher P. Protein kinase C activation inhibits glutamate-induced cytotoxicity in a neuronal cell line. Brain Res. 652:1994;169-173.
31. Maher P., Davis J. B. The role of monoamine metabolism in oxidative glutamate toxicity. J. Neurosci. 16:1996;6394-6401.
32. Ratan R. R., Murphy T. H., Baraban J. M. Oxidative stress induces apoptosis in embryonic cortical neurons. J. Neurochem. 62:1994;376-379.
33. Vogt M., Dulbecco R. Steps in the neoplastic transformation of hamster embryo cells by polyoma virus. Proc. Natl. Acad. Sci. USA. 49:1963;171-179.
34. Morimoto B. H., Koshland D. E. Induction and expression of long and short term neourosecretory potentiation in a neural cell line. Neuron. 5:1990;875-880.
35. Schubert D., Heinemann S., Carlisle W., Tarikas H., Kimes B., Steinbach J. H., Culp W., Brandt B. L. Clonal cell lines from the rat central nervous system. Nature. 249:1974;224-227.
36. Sagara Y., Dargusch R., Klier F. G., Schubert D., Behl C. Increased antioxidant enzyme activity in amyloid β protein resistant cells. J. Neurosci. 16:1996;497-505.
37. Hansen M. B., Nielsen S. E., Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell killing. J. Immunol. Meth. 119:1989;203-210.
38. Behl C., Davis J. B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid β protein toxicity. Cell. 77:1994;817-827.
39. Abe K., Kimura H. Amyloid β toxicity consists of a Ca-independent early phase and a Ca-dependent late phase. J. Neurochem. 67:1996;2074-2078.
40. Chomczynski P., Sacchi N. Single step method of RNA isolation by acid-thiocyanate phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
41. Kimura H., Fischer W. H., Schubert D. Structure, expression and function of a Schwannoma-derived growth factor. Nature. 348:1990;257-260.
42. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione applications to mammalian blood and other tissues . Anal. Biochem. 27:1969;502-522.
43. Griffith O. W. Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106:1980;207-212.
44. Aebi H. Methods of enzymatic analysis. Bergmeyer H. Catalase. I. 1974;673-684 Academic Press, New York.
45. Günzler W., Flohe L. Glutathione peroxidase. Greenwald R. Handbook of methods for oxygen radical research. 1985;285-290 CRC Press, Boca Raton, FL.
46. McCord J. M., Fridovich I. Superoxide dismutase An enzymic function for erythrocuperin (hemocuperin) . J. Biol. Chem. 244:1969;6049-6055.
47. Seelig G. F., Meister A. Glutamyl biosynthesis γ-glutamylcysteine synthetase from rat kidney . Meth. Enzymol. 113:1985;379-392.
48. Carlberg I., Mannervik B. Glutathione reductase. Meth. Enzymol. 113:1985;484-490.
49. Warholm M., Guthenberg C., von Bahr C., Mannervik B. Glutathione transferases from human liver. Meth. Enzymol. 113:1985;499-504.
50. Bass D. A., Parce J. W., Dechatelet L. R., Szejda P., Seeds M. C., Thomas M. Flow cytometric studies of oxidative product formation by neutrophils a graded response to membrane stimulation . J. Immunol. 130:1983;1910-1917.
51. Hedley D. W., Chow S. Evaluation of methods for measuring cellular glutathione content using flow cytometry. Cytometry. 15:1994;349-358.
52. Schubert D., Kimura H., Maher P. Growth factors and vitamin E modify neuronal glutamate toxicity. Proc. Natl. Acad. Sci. USA. 89:1992;8264-8267.
53. Behl C., Hovey L., Krajewski S., Schubert D., Reed J. C. BCL-2 prevents killing of neuronal cells by glutamate but not by amyloid beta protein. Biochem. Biophys. Res. Comm. 197:1993;949-956.
54. Froissard P., Monrocq H., Duval D. Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells. Eur. J. Pharmacol. 326:1997;93-99.
55. Bridges R. J., Stanley M. S., Anderson M. W., Cotman C. W., Chamberlin A. R. Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J. Med. Chem. 34:1991;717-725.
56. Reed D. J. Cystathionine. Meth. Enzymol. 252:1995;92-102.
57. Kane, D. J.; Ord, T.; Anton, R.; Bredesen, D. E. Expression of bcl-2 inhibits necrotic neural cell death. J. Neurosci. Res. 40:269-275; 1995.
58. Lindquist S., Craig E. A. The heat shock proteins. Ann. Rev. Genet. 22:1988;631-637.
59. Barbe M., Tytell M., Gower D., Welch W. Hyperthermia protects against light damage in the rat retina. Science. 241:1988;1817-1820.
60. Chopp M., Chen H., Ho K. -L., Dereski M. O., Brown E., Hetzel F. W., Welch K. M. Transient hyperthermia protects against subsequent forebrain ischemic cell damage in the rat. Neurol. 39:1989;1396-1398.
61. Rordorf G., Koroshetz W. J., Bonventre J. V. Heat shock protects cultured neurons from glutamate toxicity. Neuron. 7:1991;1043-1051.
62. Lowenstein D. H., Chan P. H., Miles M. F. The stress protein response in cultured neurons characterization and evidence for a protective role in excitotoxicity . Neuron. 7:1991;1053-1060.
63. Simon M. M., Reikerstorfer A., Schwarz A., Krone C., Luger T. A., Jäättelä M., Schwarz T. Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. J. Clin. Invest. 95:1995;926-933.
64. Saunders E. L., Maines M. D., Meredith M. J., Freeman M. L. Enhancement of heme oxygenase-1 synthesis by glutathione depletion in Chinese hamster ovary cells. Arch. Biochem. Biophys. 288:1991;368-373.
65. Ewing J. F., Maines M. D. Glutathione depletion induces heme oxygenase-1 (HSP32) mRNA and protein in rat brain. J. Neurochem. 60:1993;1512-1519.
66. Maines M. D. Heme oxygenase function, multiplicity, regulatory mechanisms, and clinical applications . FASEB J. 2:1988;2557-2568.
67. Stocker P., Glazer A. N., Ames B. N. Antioxidant activity of albumin bound bilirubin. Proc. Natl. Acad. Sci. USA. 84:1987;5918-5923.
68. Stocker P., Yamamoto Y., McDonagh A. F., Glazer A. N., Ames B. N. Bilirubin is an antioxidant of possible physiological importance. Science. 235:1987;1043-1047.
69. Meister A., Anderson M. E. Glutathione. Ann. Rev. Biochem. 52:1983;711-760.
70. Bailey H. H., Gipp J. J., Ripple M., Wilding G., Mulcahy R. T. Increase in γ-glutamylcysteine synthetase activity and steady-state messenger RNA levels in melphalan-resistant DU-145 human prostate carcinoma cells expressing elevated glutathione levels. Cancer Res. 52:1992;5115-5118.
71. Spitz D. R., Kinter M. T., Roberts R. J. Contribution of increased glutathione content to mechanisms of oxidative stress resistance in hydrogen peroxide resistant hamster fibroblasts. J. Cell. Physiol. 165:1995;600-609.
72. Godwin A. K., Meister A., O'Dwyer P. J., Huang C. S., Hamilton T. C., Anderson M. E. High resistance to cisplatin in human ovarian cancer cell lines is associated with marked increase of glutathione synthesis. Proc. Natl. Acad. Sci. USA. 89:1992;3070-3074.
73. Meister A. Methods for the selective modification of glutathione metabolism and study of glutathione transport. Meth. Enzymol. 113:1985;571-585.
74. Griffith O. W. Mechanism of action, metabolism, and toxicity of buthionine sulfoximine and its higher homologs, potent inhibitors of glutathione synthesis. J. Biol. Chem. 258:1982;1591-1598.
75. Moore W. R., Anderson M. E., Meister A., Murata K., Kimura A. Increased capacity for glutathione synthesis enhances resistance to radiation in Escherichia coli a possible model for mammalian cell protection . Proc. Natl. Acad. Sci. USA. 86:1989;1461-1464.
76. Dolphin D., Poulson R., Avramovic O. Glutathione coenzymes and cofactors. 1988;Wiley, New York.
77. Yokomizo A., Kohno K., Wada M., Ono M., Morrow C. S., Cowan K. H., Kuwano M. Markedly decreased expression of glutathione S-transferase π gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis. J. Biol. Chem. 270:1995;19451-19457.
78. Liebmann J., Fisher J., Lipschultz C., Kuno R., Kaufman D. C. Enhanced glutathione peroxidase expression protects cells from hydroperoxides but not from radiation or doxorubicin. Cancer Res. 55:1995;4465-4470.
79. Mulcahy R. T., Bailey H. H., Gipp J. J. Transfection of complementary DNAs for the heavy and light subunits of human γ-glutamylcysteine synthetase results in an elevation of intracellular glutathione and resistance to melphalan. Cancer Res. 55:1995;4771-4775.
80. Srivastava S. K., Beutler E. The transport of oxidized glutathione from human erythrocytes. J. Biol. Chem. 244:1969;9-16.
81. Becker K., Shirmer R. H. 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) as thiol-carbamoylating agent in biological systems. Meth. Enzymol. 251:1995;173-188.
82. Anderson M. E., Meister A. Transport and direct utilization of γ-glutamylcyst(e)ine for glutathione synthesis. Proc. Natl. Acad. Sci. USA. 80:1983;707-711.
83. Forman H. J., Shi M. M., Iwamoto T., Liu R.-M., Robinson T. W. Measurement of γ-glutamyl transpeptidase and γ-glutamylcysteine synthetase activities in cells. Meth. Enzymol. 252:1995;66-71.
84. c- in cystine transport by a human pancreatic duct cell line. J. Physiol. 485:1995;167-177.
85. Kugelman A., Choy H. A., Liu R., Shi M. M., Gozal E., Forman H. J. γ-glutamyl transpeptidase is increased by oxidative stress in rat alveolar L2 epithelial cells. Am. J. Cell Molec. Biol. 11:1994;586-592.
86. Pickett C. B., Lu A. Y. Glutathione S-transferases Gene structure, regulation, and biological function . Ann. Rev. Biochem. 58:1989;743-764.
87. Nicholson D. W., Ali A., Vaillancourt J. P., Calaycay J. R., Mumford R. A., Zamboni R. J., Ford-Hutchinson A. W. Purification to homogeneity and the N-terminal sequence of a human leukotriene C4 synthase A homodimeric glutathione S-transferase composed of 18-kDa subunits . Proc. Natl. Acad. Sci. USA. 90:1993;2015-2019.
88. Cagen L. M., Pisano J. J., Ketley J. N., Habig W. H., Jakoby W. B. The conjugation of prostaglandin A1 and glutathione catalyzed by homogeneous glutathione S-transferases from human and rat liver. Biochim. Biophys. Acta. 398:1975;205-208.
89. Mannervik B. The isoenzymes of glutathione transferase. Adv. Enzymol. Relat. Areas Molec. Biol. 57:1985;357-417.
90. Ketterer B., Tan K. H., Meyer D. J., Coles B. Glutathione transferases a possible role in the detoxification of DNA and lipid hydroperoxides . Mantle T. J., Pickett C. B., Hayes J. D. Glutathione S-transferases and carcinogenesis. 1987;149-164 Taylor & Francis, London.
91. Beckett G. J., Hayes J. D. Glutathione S-transferases Biomedical applications . Adv. Clin. Chem. 30:1993;281-380.
92. Tew K. D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res. 54:1994;4313-4320.
93. Colvin O. M. Mechanisms of resistance to alkylating agents. Goldstein L. J., Ozols R. F. Anticancer drug resistance advances in molecular and clinical research . 1994;249-262 Academic Press, New York.
94. Ploemen J. H. T. M., Van Schanke A. V., Van Ommen B. V., Van Bladeren P. J. Reversible conjugation of ethacrynic acid with glutathione and human glutathione S-transferase P1-1. Cancer Res. 54:1994;915-919.
95. Phillips M. F., Mantle T. J. Inactivation of mouse liver glutathione S-transferase YfYf (Pi class) by ethacrynic acid and 5,5′-dithiobis-(2-nitrobenzoic acid). Biochem. J. 275:1991;703-709.
96. Bolton M. G., Colvin O. M., Hilton J. Specificity of isozymes of murine hepatic glutathione S-transferase for the conjugation of glutathione with L-phenylalanine mustard. Cancer Res. 51:1991;2410-2415.
97. Muller J. G., Bucheler U. S., Kayser K., Schirmer R. H., Werner D., Krauth-Siegel R. L. Glutathione reductase in human and murine lung tumors high levels of mRNA and enzymatic activity . Cell. Molec. Biol. 39:1993;389-396.
98. Hart B. A., Gong Q., Eneman J. D., Durieux-Lu C. C., Kimberly P., Hacker M. P. Increased oxidant resistance of alveolar macrophages isolated from rats repeatedly exposed to cadmium aerosols. Toxicol. 107:1996;163-175.
99. Rickman P., Meister A. Regulation of γ-glutamylcysteine synthetase by nonallosteric feedback inhibition by glutathione. J. Biol. Chem. 254:1975;7558-7560.
100. Woods J. S., Ellis M. E. Up-regulation of glutathione synthesis in rat kidney by methyl mercury. Relationship to mercury-induced oxidative stress. Biochem. Pharmacol. 50:1995;1719-1724.
101. Miyamoto M., Murphy T. H., Schnaar R. L., Coyle J. T. Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line. J. Pharmacol. Exp. Ther. 250:1989;1132-1140.
102. Greenlund L. J. S., Deckwerth T. L., Johnson E. M. Jr. Superoxide dismutase delays neuronal apoptosis a role for reactive oxygen species in programmed neuronal death . Neuron. 14:1995;303-315.
103. Prehn J. H., Bindokas V. P., Jordan J., Galindo M. F., et al. Protective effect of transforming growth factor-beta 1 on beta-amyloid neurotoxicity in rat hippocampal neurons. Molec. Pharmacol. 49:1996;319-328.
104. Bar-Peled O., Korkotian E., Segal M., Groner Y. Constitutive overexpression of Cu/Zn superoxide dismutase exacerbates kainic acid-induced apoptosis of transgenic-Cu/Zn superoxide dismutase neurons. Proc. Natl. Acad. Sci. USA. 93:1996;8530-8535.
105. Tan K. H., Meyer D. J., Coles B., Ketterer B. Thymine hydroperoxide, a substrate for rat Se-dependent glutathione peroxidase and glutathione transferase isoenzymes. FEBS. 207:1986;231-233.
106. Tan K. H., Meyer D. J., Gillies N., Ketterer B. Detoxification of DNA hydroperoxide by glutathione transferases and the purification and characterization of glutathione transferases of the rat liver nucleus. Biochem. J. 254:1988;841-845.
107. Johnson J. A., El Barbary A., Kornguth S. E., Brugge J. F. Glutathione S-transferase isoenzymes in rat brain neurons and glia. J. Neurosci. 13:1993;2013-2023.
108. Philbert M. A., Beiswanger C. M., Manson M. M., Green J. A., Novak R. F., Primiano T., Reuhl K. R., Lowndes H. E. Glutathione S-transferases and γ-glutamyl transpeptidase in the rat nervous system A basis for differential susceptibility to neurotoxicants . NeuroToxicol. 16:1995;349-362.
109. Perry T. L., Godin D. V., Hansen S. Parkinson's disease A disorder due to nigral glutathione deficiency? Neurosci. Lett. 33:1982;305-310.
110. Sian J., Dexter D. T., Lees A. J., Daniels S., Agid Y., Javoy-Agid F., Jenner P., Marsden C. D. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia. Ann. Neurol. 36:1994;348-355.
111. Shivakumar B. R., Kolluri S. V. R., Ravindranath V. Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia. J. Pharmacol. Exp. Ther. 274:1995;1167-1173.
112. Chen T. S., Richie J. P. Jr, Lang C. A. The effect of aging on glutathione and cysteine levels in different regions of the mouse brain. Proc. Soc. Exp. Biol. Med. 190:1989;399-402.
113. Benzi G., Pastoris O., Gorini A., Marzatico F., Villa R. F., Curti D. Influence of aging on the acute depletion of reduced glutathione induced by electrophilic agents. Neurobiol. Aging. 12:1991;227-231.
114. Adams J. D. Jr, Klaidman L. K., Odunze I. N., Shen H. C., Miller C. A. Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Molec. Chem. Neuropathol. 14:1991;213-225.
115. Lovell M. A., Ehmann W. D., Butler S. M., Markesbery W. R. Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurol. 45:1995;1594-1601.
116. Meredith M. J., Reed D. J. Depletion in vitro of mitochondrial glutathione in rat hepatocyte and enhancement of lipid peroxidation by adriamycin and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU). Biochem. Pharmacol. 32:1983;1383-1388.
117. Fahey R. C., Newton G. L., Arrick B., Overdank-Bogart T., Aley S. B. Entamoeba histolytica a eukaryote without glutathione metabolism . Science. 224:1984;70-72.